2018
SLN biopsy in cervical cancer patients with tumors larger than 2 cm and 4 cm
DOSTALEK, L.; M. ZIKAN; D. FISCHEROVA; R. KOCIAN; A. GERMANOVA et. al.Základní údaje
Originální název
SLN biopsy in cervical cancer patients with tumors larger than 2 cm and 4 cm
Autoři
DOSTALEK, L.; M. ZIKAN; D. FISCHEROVA; R. KOCIAN; A. GERMANOVA; F. FRUHAUF; Ladislav DUŠEK; J. SLAMA; P. DUNDR; K. NEMEJCOVA a D. CIBULA
Vydání
Gynecologic Oncology, SAN DIEGO, ACADEMIC PRESS INC ELSEVIER SCIENCE, 2018, 0090-8258
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30214 Obstetrics and gynaecology
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 4.393
Kód RIV
RIV/00216224:14110/18:00102807
Organizační jednotka
Lékařská fakulta
UT WoS
000428005300005
EID Scopus
2-s2.0-85040686409
Klíčová slova anglicky
Cervical cancer; Bulky; Sentinel lymph node; False negative rate; Detection rate; Sensitivity
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 10. 2. 2019 19:41, Soňa Böhmová
Anotace
V originále
Objectives. The aim of this study was to assess the detection rate, false-negative rate and sensitivity of SLN in LN staging in tumors over 2 cm on a large cohort of patients. Methods. Data from patients with stages pT1a - pT2 cervical cancer who underwent surgical treatment, including SLN biopsy followed by systematic pelvic lymphadenectomy, were retrospectively analyzed. A combined technique with blue dye and radiocolloid was modified in larger tumors to inject the tracer into the residual cervical stroma. Results. The study included 350 patients with stages pTla - pT2. Macrometastases, micrometastases, and isolated tumor cells were found in 10%, 8%, and 4% of cases. Bilateral detection rate was similar in subgroups with tumors < 2 cm, 2-3.9 cm, and >= 4 cm (79%, 83%, 76%) (P = 0.460). There were only two cases with false-negative SLN ultrastaging for pelvic IN status among those with bilateral SLN detection. The false negative rate was very low in all three subgroups of different tumor sizes (0.9%, 0.9%, and 0.0%; P = 0.999). Sensitivity reached 96% in the whole group and was high in all three groups (93%, 93%, 100%; P = 0.510). Conclusions. If the tracer application technique is adjusted in larger tumors, SIN biopsy can be equally reliable in pelvic IN staging in tumors smaller and larger than 2 cm. The bilateral detection rate and false negative rate did not differ in subgroups of patients with tumors < 2 cm, 2-3.9 cm, and cm.